Alfa Laval delivers upstream and downstream bioprocessing technologies, validation documentation, and predictive condition monitoring equipment for pharmaceutical manufacturers.
Fraunhofer IKTS develops specialized dressings designed to address chronic wounds, improve healing outcomes and offer new approaches to infection prevention.
PhysioINK uses collagen, elastin and cellulose derivatives to create printable bioinks for tissue models, drug development and future regenerative medicine.
NEURA Robotics introduces an AI-driven healthcare platform designed to streamline hospital infrastructure by automating the transport of empty beds and sterile supplies.
Siemens Healthineers launches the Innovance D-Dimer 2.0 assay to enhance diagnostic evaluation and workflow efficiency for venous thromboembolism and hypercoagulable conditions.
Healthcare’s most vulnerable populations require specialized medical technology designed specifically for their physiological stage rather than adapted from adult alternatives.
Siemens Healthineers introduces Accela, a software-driven radiotherapy solution engineered around dynamic modulated arc therapy to scale complex cancer treatments.